Key Metrics
10
CiteScore
CiteScore
CiteScore measures average citations received per document published in the serial.
5 - 10
Impact Factor
Impact Factor
Impact factor of a journal is calculated by dividing the number of current year citations to the source items published in that journal during the previous two years.
0.9
5-Year SI
5-year SI
- N/A 2-year SI
- 0.88 Lifetime SI
Scite Index
Scite Index
scite Index is the ratio of citations supporting research which is published in the journal to sum of citations either supporting or contrasting the research published in the journal for the same time period. Minimum 100 supporting citations required.
1.25
SNIP
SNIP
Source Normalized Impact per Paper measures actual citations received relative to citations expected for the serial’s subject field.
5 Mo
Time to Publish
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
Journal Specifications
| Overview | |
| Publisher | SPRINGER |
| Language | English |
| Frequency | Monthly |
| General Details | |
| Language | English |
| Frequency | Monthly |
| Publication Start Year | 1976 |
| Publisher URL | Visit website |
| Website URL | Visit website |
Planning to publish in Cancer Immunology, Immunotherapy ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Looking for the right journals to submit your mansucript?
Upload your manuscript and get a submission readiness score and other journal recommendations.
Check my PaperRecently Published Papers
-
Full paper
Targeted therapies in retinoblastoma: GD2-directed immunotherapy following autologous stem cell transplantation and evaluation of alternative target B7-H3
- 1 Jan 24
- Cancer Immunology, Immunotherapy
-
Full paper
Generation and assessment of cytokine-induced killer cells for the treatment of colorectal cancer liver metastases
- 1 Jan 24
- Cancer Immunology, Immunotherapy
-
Full paper
A novel model for predicting prognosis and response to immunotherapy in nasopharyngeal carcinoma patients
- 1 Jan 24
- Cancer Immunology, Immunotherapy
-
Full paper
Rescue of NLRC5 expression restores antigen processing machinery in head and neck cancer cells lacking functional STAT1 and p53
- 1 Jan 24
- Cancer Immunology, Immunotherapy
-
Full paper
Vaccination against neoantigens induced in cross-priming cDC1 in vivo
- 1 Jan 24
- Cancer Immunology, Immunotherapy
-
Full paper
Real-world outcomes of nivolumab plus ipilimumab and pembrolizumab with platinum-based chemotherapy in advanced non-small cell lung cancer: a multicenter retrospective comparative study
- 1 Jan 24
- Cancer Immunology, Immunotherapy
Scite analysis
Powered by scite_
6.8k articles received 137.4k citations see all
- 5,284 Supporting
- 129,800 Mentioning
- 673 Contrasting
Editorial notices
- 3 Retractions
- 0 Withdrawals
- 59 Corrections
- 53 Errata
- 0 Expression of Concern
Time To Publish
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
% of papers by time taken from submission to publication
0 to 3 months
14%
4 to 6 months
46%
7 to 9 months
29%
Above 9 months
11%
Did you find this useful?
Thank you for your feedback.
FAQs
How long has Cancer Immunology, Immunotherapy been actively publishing?
Cancer Immunology, Immunotherapy has been in operation since 1976 till date.
What is the publishing frequency of Cancer Immunology, Immunotherapy ?
Cancer Immunology, Immunotherapy published with a Monthly frequency.
How many articles did Cancer Immunology, Immunotherapy publish last years ?
In 2023, Cancer Immunology, Immunotherapy published 88 articles.
What is the eISSN & pISSN for Cancer Immunology, Immunotherapy ?
For Cancer Immunology, Immunotherapy,eISSN is 1432-0851 and pISSN is0340-7004.
What is Citescore for Cancer Immunology, Immunotherapy ?
Citescore for Cancer Immunology, Immunotherapy is 10.
What is SNIP score for Cancer Immunology, Immunotherapy ?
SNIP score for Cancer Immunology, Immunotherapy is 1.25.
Who is the publisher of Cancer Immunology, Immunotherapy ?
SPRINGER is the publisher of Cancer Immunology, Immunotherapy.